Cloning and heterologous expression of P450Lent4B11, a novel bacterial P450 gene, for hydroxylation of an antifungal agent sordaricin
- 1 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Journal of Antibiotics
- Vol. 73 (9), 615-621
- https://doi.org/10.1038/s41429-020-0310-9
Abstract
Microbial transformation is known to be one of promising options to add functional groups such as a hydroxyl moiety to active base compounds to generate their derivatives. Sordaricin, a diterpene aglycone of the natural product sordarin, is an antifungal agent to selectively inhibit fungal protein synthesis by stabilizing the ribosome/EF-2 (elongation factor 2) complex. We screened actinomycetes to catalyze hydroxylation of sordaricin on the basis that the hydroxyl moiety would make it easier to generate derivatives of sordaricin. As a result of the screening, 6-hydroxylation of sordaricin was found to be catalyzed by Lentzea sp. 7887. We found that the cytochrome P450 inhibitor metyrapone inhibited this reaction, suggesting that a cytochrome P450 may be responsible for the biotransformation. As a next step, we cloned multiple cytochrome P450 genes, one of which were named P450Lent4B11, using degenerate PCR primers. The expressed cytochrome P450 derived from the P450Lent4B11 gene provided a different absorbance spectrum pattern from original one when it was incubated with sordaricin. Moreover, in cell-free conditions, the corresponding cytochrome P450 displayed the 6-hydroxylation activity toward sordaricin. Taken together, these results indicate that P450Lent4B11, derived from Lentzea sp. 7887, should be responsible for catalyzing 6-hydroxylation of sordaricin.This publication has 26 references indexed in Scilit:
- Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450Microbial Cell Factories, 2013
- Hidden Killers: Human Fungal InfectionsScience Translational Medicine, 2012
- Cloning and heterologous expression of P450Um-1, a novel bacterial P450 gene, for hydroxylation of immunosuppressive agent AS1387392The Journal of Antibiotics, 2010
- Bioconversion of vitamin D to its active form by bacterial or mammalian cytochrome P450Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Sordarin, an antifungal agent with a unique mode of actionBeilstein Journal of Organic Chemistry, 2008
- Oxidative activities of heterologously expressed CYP107B1 and CYP105D1 in whole-cell biotransformation using Streptomyces lividans TK24Journal of Bioscience and Bioengineering, 2005
- Sordaricin antifungal agentsBioorganic & Medicinal Chemistry Letters, 2003
- Structure and function of cytochromes P450:a comparative analysis of three crystal structuresStructure, 1995
- Crystal Structure of Hemoprotein Domain of P450BM-3, a Prototype for Microsomal P450'sScience, 1993
- Isolierung und Abbau von Sordarin. 1. Mitteilung über SordarinHelvetica Chimica Acta, 1971